The UK medicines regulator announced Monday that it has approved a new generation of Moderna's COVID-19 vaccine targeting the Omicron variant, a world first according to the lab. < /p>
This version of the vaccine consists of a booster dose targeting half the original strain of the virus and half the Omicron variant and “induces a strong immune response” against both, including the subvariants d 'Omicron BA.4 and BA.5, with “low” side effects similar to those seen with the original serums, the MHRA said in a statement.
Katrine Johns has been a reporter on the news desk since 2013. Before that she wrote about young adolescence and family dynamics for Styles and was the legal affairs correspondent for the Metro desk. Before joining The Gal Post, Katrine Johns worked as a staff writer at the Village Voice and a freelancer for Newsday, The Wall Street Journal, GQ and Mirabella. To get in touch, contact me through my email@example.com 1-800-268-7128